论文部分内容阅读
本院于１９９７年６月～１９９８年５月，应用干扰素（ＩＦＮ－ａｌｂ，商品名赛若金，深圳科兴生物制品有限公司）联合化疗治疗非霍奇金恶性淋巴瘤（ＮＨＬ）２６例，取得了较为满意的疗效。现报告如下。材料与方法一、研究对象：１９９７年６月～１９９８年５月的住院病例５?
From June 1997 to May 1998, 26 patients with non-Hodgkin’s malignant lymphoma (NHL) were treated with IFN-alb (trade name Sai Ruojin, Shenzhen Kexing Biological Products Co., Ltd.) combined with chemotherapy. , Has achieved a more satisfactory effect. The report is as follows. Materials and Methods 1. Research object: 5 to 5 inpatient cases from June 1997 to May 1998.